BRIEF-EU health agency recommends approval of new hepatitis C drugs
May 27, 2016 at 07:21 AM EDT
* Recommends against approval of Takeda Pharmaceutical Co Ltd's ixazomib to treat multiple myeloma
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.